The effect of sodium-glucose co-transporter-2 inhibitors on markers of subclinical atherosclerosis

Panagiotis Stachteasa Second Department of Cardiology, Aristotle University of Thessaloniki, Thessaloniki, GreeceView further author information

Paschalis Karakasisa Second Department of Cardiology, Aristotle University of Thessaloniki, Thessaloniki, Greece

https://orcid.org/0000-0002-3561-5713 View further author information

Dimitrios Patouliasb Outpatient Department of Cardiometabolic Medicine, Second Department of Cardiology, Aristotle University of Thessaloniki, Thessaloniki, GreeceCorrespondence[email protected]
View further author information

Francesco Clemenzac Department for the Study and Treatment of Cardiothoracic Diseases and for Cardiothoracic Transplants, Cardiology Unit, IRCCS – ISMETT, Palermo, ItalyView further author information

Nikolaos Fragakisa Second Department of Cardiology, Aristotle University of Thessaloniki, Thessaloniki, Greece;b Outpatient Department of Cardiometabolic Medicine, Second Department of Cardiology, Aristotle University of Thessaloniki, Thessaloniki, GreeceView further author information

Manfredi Rizzod Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates;e Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Promise), School of Medicine, University of Palermo, Palermo, ItalyView further author information

The effect of sodium-glucose co-transporter-2 inhibitors on markers of subclinical atherosclerosis

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The effect of sodium-glucose co-transporter-2 inhibitors on markers of subclinical atherosclerosis

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date